Eloxx Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $4.8M | $111.0K | $1.1M | $19.2M | $42.3M | $24.7M | $22.5M | $48.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $5.3M | $3.0M | $1.5M | $20.1M | $43.5M | $25.9M | $57.7M | $50.3M |
| Property, Plant & Equipment | $0 | $0 | $35.0K | $169.0K | $216.0K | $133.0K | $201.0K | $248.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $5.3M | $3.0M | $1.7M | $21.1M | $45.1M | $26.5M | $58.9M | $50.7M |
| Liabilities | ||||||||
| Accounts Payable | $2.7M | $5.3M | $5.7M | $3.0M | $1.4M | $481.0K | $1.9M | $747.0K |
| Total Current Liabilities | $17.2M | $27.3M | $22.7M | $23.1M | $10.0M | $9.8M | $11.8M | $7.8M |
| Long-Term Debt | $0 | $0 | $1.6M | $8.6M | $12.0M | $6.4M | $10.5M | — |
| Total Liabilities | $17.2M | $27.3M | $24.3M | $31.8M | $22.8M | $16.2M | $22.7M | $7.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-300.6M | $-294.6M | $-291.4M | $-274.4M | $-238.3M | $-171.6M | $-137.0M | $-86.1M |
| Total Stockholders' Equity | $-11.9M | $-24.3M | $-22.6M | $-10.7M | $22.4M | $10.2M | $36.2M | $42.9M |